M 943 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint M 943 is Blue, Round and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 943

Save up to 80% off prescription medications

Click here for your free Discount Card

Divalproex Sodium Delayed-Release

Imprint

M 943

Strength

125 mg

Color

Blue

Size

9.00 mm

Shape

Round

Availability

Prescription only

Drug Class

Fatty acid derivative anticonvulsants

Pregnancy Category

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine

CSA Schedule

Not a controlled drug

Labeler / Supplier

Mylan Pharmaceuticals Inc.

National Drug Code (NDC)

00378-1043

Inactive Ingredients

ferrosoferric oxide, silicon dioxide, copovidone, croscarmellose sodium, FD&C Blue No. 2, FD&C Yellow No. 6, hypromelloses, lactose monohydrate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, polydextrose, polyethylene glycol, polysorbate 80, polyvinyl alcohol, propylene glycol, sodium hydroxide, magnesium silicate, titanium dioxide, triacetin, triethyl citrate

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "M 943"

Diazepam

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer